Showing 751-760 of 23022 results for "".
Asthma Risk Factors: Trends Beyond the Hygiene Hypothesis
https://reachmd.com/programs/focus-on-allergy/asthma-risk-factors-trends-beyond-the-hygiene-hypothesis/4376/The incidence of asthma has doubled in the past two decades, though the cause of this rise is difficult to pinpoint. While the hygiene hypothesis has, for years, served as one possible explanation, newer studies show a possible link between asthma and vitamin levels or exposure to certain chemicalsSevere Brain Trauma: Lessons from Army Medicine
https://reachmd.com/programs/the-strength-to-heal/severe-brain-trauma-lessons-from-army-medicine/3267/Many brain trauma injuries suffered in the current conflicts abroad are unparalleled in severity. At the same time, procedural advances are allowing for unprecedented rates of survival and returns to functional quality of life. Col. Dr. Leon Moores, former chief of neurosurgery at Walter Reed Army MChallenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
https://reachmd.com/programs/medical-industry-feature/challenging-cases-iga-nephropathy-specialized-care/29536/IgA nephropathy is a heterogeneous disease with variable clinical presentation. Learn more about its pathogenesis, diagnostic considerations, and complex cases as Dr. Jaimini Patel sits down with Dr. Sayna Norouzi, Associate Professor of Medicine and clinical nephrologist at Loma Linda University MeInterstitial Pneumonia with Autoimmune Features (IPAF): A Research Classification
https://reachmd.com/programs/cme/interstitial-pneumonia-with-autoimmune-features-ipaf-a-research-classification/10943/Just what exactly is IPAF, and how can I help my patients?Medical Tales From The Fire Chief ,Over 28 Years
https://reachmd.com/programs/clinicians-roundtable/medical-tales-from-the-fire-chief-over-28-years/2022/Fire Battalion Chief Charles Orth of Wilmette, Illinois Fire Department, as 28 year veteran of the force. Chief Orth is also the medical officer for the department, has been a paramedic for the last 26 years, and is an Illinois State Fire investigator discusses health care stories from his 28 yearsEMS System: It's Beginning and Where is it Going?
https://reachmd.com/programs/clinicians-roundtable/ems-system-its-beginning-and-where-is-it-going/2020/Fire Battalion Chief Charles Orth of Wilmette, Illinois Fire Department, as 28 year veteran of the force. Chief Orth is also the medical officer for the department, has been a paramedic for the last 26 years, and is an Illinois State Fire investigator is discussing the EMS system, when did it beginBeyond RAASi and Approved Therapies: The Unmet Needs in IgAN
https://reachmd.com/programs/cme/beyond-raasi-and-approved-therapies-the-unmet-needs-in-igan/54683/Drs. Lafayette, Risk, Suzuki, and Zhang discuss how APRIL fits into the 4-hit hypothesis of IgAN pathogenesis and review emerging disease-modifying therapies.Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
https://reachmd.com/programs/cme/spotlight-on-systemic-sclerosis-pathophysiology-presentation-emerging-evidence/48716/Systemic sclerosis (SSc) is complex and often diagnosed late. Explore the vasculopathy-fibrosis axis as a key driver of disease progression and clinical manifestations. Learn to recognize phenotypic red flags for ILD, PAH, and renal crisis, and apply risk stratification strategies to guide earlier iOn Paper: The Evolution of Medical Media
https://reachmd.com/programs/partners-in-practice/on-paper-the-evolution-of-medical-media/6287/As the medical publishing industry evolves, and journals expand into non-print new media, it's a good time to explore the function of medical journals in the professional lives of PAs and NPs. Will the experience of receiving a journal in the mail soon be a thing of the past? What do we get out of pAre All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
https://reachmd.com/programs/cme/are-all-vmat2s-the-same-data-driven-treatment-decisions-for-tardive-dyskinesia/36174/Join us to learn about the emerging data with VMAT2 inhibitors for the treatment of tardive dyskinesia.